Article thumbnail

Summary of adverse events for patients with severe renal impairment<sup>a</sup>.

By Graham R. Foster (2577061), Tarik Asselah (717526), Sarah Kopecky-Bromberg (6169418), Yang Lei (136316), Armen Asatryan (6169421), Roger Trinh (6169424), Neddie Zadeikis (6169427) and Federico J. Mensa (835711)

Abstract

<p>Summary of adverse events for patients with severe renal impairment<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0208506#t004fn002" target="_blank"><sup>a</sup></a>.</p

Topics: Medicine, Microbiology, Immunology, Cancer, Science Policy, Infectious Diseases, Virology, post-treatment week 12, GT, age 65 years, 9 Phase 2, HCV infection, virologic response rates, hepatitis C virus, CI, DAA, AE, well-tolerated treatment option, SVR 12 rates
Year: 2019
DOI identifier: 10.1371/journal.pone.0208506.t004
OAI identifier: oai:figshare.com:article/7540016
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.plosone.org/article... (external link)
  • https://figshare.com/articles/... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.